NRx Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$30,150,000 over the previous period. Total operating expenses were $27,582,000.
Profit Margin
| 2017 | 0 | -105.03K | |
|---|---|---|---|
| 2018 | 0 | 66.10K | |
| 2019 | 0 | 408.42K | |
| 2020 | 0 | -12.34M | |
| 2021 | 0 | -71.71M | |
| 2022 | 0 | -35.23M | |
| 2023 | 0 | -30.15M |
NRXPW Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 5K | 4K | 2K | 907.40K | 0 | 1.00M | 0 |
Gross profit | -5K | -4K | -2K | -907.40K | 0 | -1.00M | 0 |
Operating exp. | |||||||
Research and development | 13.37M | 17.02M | 20.25M | 10.62M | 3.49K | 0 | 0 |
Selling and marketing | -5K | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 27.58M | 44.39M | 94.43M | 11.90M | 6.42K | 1.00M | 0 |
Operating income | -27.58M | -44.39M | -115.79M | -51.38M | -6.26K | -1.00M | 0 |
Other income (expenses), net | -2.57M | 4.58M | 22.73M | -39.87M | 492.63K | 1.08M | -105.03K |
Income before tax | -30.15M | -39.81M | -93.06M | -51.77M | 492.63K | 82.41K | -105.03K |
Income tax expense | -9K | -4.58M | -21.34M | -39.43M | 84.20K | 16.31K | 0 |
Net income | -30.15M | -35.23M | -71.71M | -12.34M | 408.42K | 66.10K | -105.03K |
Earnings per share | |||||||
Basic EPS | -3.98 | -0.54 | -1.53 | -0.36 | 0.8 | 0.02 | -0.12 |
Diluted EPS | -3.98 | -0.54 | -1.53 | -0.36 | 0.8 | 0.02 | -0.12 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |